A study has formed little days earlier at Johns Hopkins University of Medicine by the Indian Origin scientist which has suggested that healthy smokers of middle age take most of the time anti smoking drug on the market. Aside from that they all are be aware of the fact that it may even lead them towards hospital with a heart attack or serious heart problem than those who takes a placebo.

To fulfilling this fact Sonal Singh, assistant professor of general internal medicine of Johns Hopkins University School of Medicine as well as the leader of the study, said “In general cases people want to quit smoking in order to reduce the risk of cardiovascular disease, but in this matter they are taking drug which may even increase the risk of heart attack, though they are taking that in order to get relief from that disease.”

During the period of entire study Sings and his colleagues analyzed and reviewed 14 double blind, controlled and randomized clinical trial. Even they also involved more than 8,200 healthy people and divide them into two groups. One group they provided varenicline with made by Pfizer and general in United State this was sold under the brand name of Chantix and a placebo to the other group. But they found that the number died in each group was the same or seven members of each group. Moreover, they even noticed that this drug increased the risks of heart attack and arrhythmia by 72 percent which may even send them towards hospital.

Aside from that Singh’s study visualized that varenicline substantially quite being able to increase serious cardio vascular event risks even among those smokers who were without a heart problem or disease.

Singh also said “I am very glad that this new research shifts the risk benefit of varenicline.”   With the sequence to the fact he also added “People have to be much more concern about this fact and I think they do not need Chantix in order to quit their smoking which is already standing at the gateway of heart attack or other cardio vascular disease. ”

The entire study was published at the Journal of Canadian Medical Association few days back.